DAGCO Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-204
Closed -$187K 234
2026
Q1
$187K Hold
204
0.04% 105
2025
Q4
$219K Buy
204
+1
+0.5% +$956 0.05% 94
2025
Q3
$155K Buy
203
+40
+25% +$29.8K 0.04% 112
2025
Q2
$127K Hold
163
0.04% 118
2025
Q1
$135K Buy
+163
New +$136K 0.04% 103
2024
Q1
Sell
-135
Closed -$78.7K 322
2023
Q4
$78.7K Buy
+135
New +$78.8K 0.07% 108

Other funds holding LLY

DAGCO Inc's LLY Position: Q2 2026 in Review

DAGCO Inc sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 204 shares — an estimated $187K sold.

DAGCO Inc first reported a position in LLY in Q4 2023 and held it in 6 quarters. The position peaked at $219K in Q4 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • DAGCO Inc reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • DAGCO Inc sold 204 Eli Lilly shares in Q2 2026, an estimated $187K.
  • DAGCO Inc first reported a position in Eli Lilly in Q4 2023 and held it in 6 quarters.
  • DAGCO Inc's Eli Lilly position peaked at $219K in Q4 2025.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DAGCO Inc's 13F filing for Q2 2026, filed 10 Jul 2026.